
|Articles|August 1, 2001
- Pharmaceutical Executive-08-01-2001
- Volume 0
- Issue 0
Generics: Streamline and Stimulate
Author(s)Kevin Gopal
Brussels-Lack of intellectual property protection is not causing the erosion of European pharma, reports the European Generics Association.
Advertisement
Articles in this issue
almost 25 years ago
Decision Making at Digital Speedalmost 25 years ago
Mergers: Big Pharma Shrinks Somealmost 25 years ago
Grace Under Firealmost 25 years ago
Get Ready to Merge or Divergealmost 25 years ago
Pharma's Quantum Shufflealmost 25 years ago
Science-Driven MarketingAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
2
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
3
The New Healthy Aging Imperative and What It Means for Pharma
4
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
5




